Also trades as: THC.CN (CNQ) · $vol 0M
THCBF OTC
THC Biomed Intl Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +99900.0%
1Y: +0.0%
3Y: -95.3%
5Y: -98.7%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
-35.1% ▼
5Y CAGR: +110.1%
Gross Profit
-$1M
+67.6% ▲
Operating Income
-$3M
+54.3% ▲
Net Income
-$3M
+51.8% ▲
EPS (Diluted)
$-0.02
+51.9% ▲
EBITDA
-$2M
+67.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $925K | $1M | $4M | $4M | $2M |
| YoY Growth | +1445.4% | +61.0% | +180.5% | -9.7% | -35.1% |
| Cost of Revenue | $458K | -$13K | $934K | $7M | $4M |
| Gross Profit | $467K | $2M | $3M | -$3M | -$1M |
| Gross Margin | 50.5% | 100.9% | 77.6% | -84.1% | -42.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3M | $6M | $2M | $2M | $1M |
| Operating Expenses | $3M | $6M | $3M | $3M | $2M |
| Operating Income | -$2M | -$5M | $205K | -$6M | -$3M |
| Operating Margin | -260.5% | -318.4% | 4.9% | -157.3% | -110.6% |
| Interest Expense | $159K | $98K | $361K | $422K | $501K |
| Income Before Tax | -$12M | -$13M | -$162K | -$6M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$12M | -$13M | -$162K | -$6M | -$3M |
| Net Margin | -1346.4% | -852.5% | -3.9% | -168.5% | -125.2% |
| EPS (Diluted) | $-0.11 | $-0.10 | $-0.00 | $-0.04 | $-0.02 |
| EBITDA | -$2M | -$12M | $1M | -$5M | -$2M |
| Shares Outstanding | 112M | 133M | 156M | 164M | 164M |